Opioid gene variant in adolescents reduces reward, may increase later substance abuse risk

Credit: CC0 Public Domain

Adolescents with a particular variant of an opioid receptor gene have less response in a part of prefrontal cortex that evaluates rewards, compared to those with the other version of the gene, say researchers at Georgetown University Medical Center (GUMC).

For the study, presented Monday at Neuroscience 2018, the annual meeting of the Society for Neuroscience (abstract #7517), the investigators scanned who have never used drugs or alcohol with imaging (fMRI) while they played a simplified "gambling" game. In some participants, researchers found a muted reward response when the participants were shown when they won, versus lost, a small amount of money.

These results suggest that adolescents with a particular variant of an opioid receptor may be more vulnerable to substance abuse in later years, says the study's senior investigator, John VanMeter, Ph.D., director of the Center for Functional and Molecular Imaging at GUMC, and an associate professor of neurology.

A possible reason this gene may confer risk is that the diminished response to rewards may compel an individual to over indulge to achieve the same level of pleasure others without the gene variant do, VanMeter says. "Combined with the fact the prefrontal cortex is still developing in adolescence, this may lead to an increased risk for future substance use problems."

The gene in question is the G variant (or allele) of mu (OPRM1). In the brain mu-opioid receptors respond to both internal (e.g., endorphins—such as "runner's high") and external opioids (e.g., morphine and oxycontin used for pain management). The reason the researchers chose to investigate this gene is because a number of studies have linked it to substance abuse. For example, it is more commonly found in adult heroin addicts, and adolescents who have an alcohol use disorder were more than three times likely to have the G-variant, say the researchers.

Adolescents are believed to be at increased risk of misusing drugs because of the differing rates at which parts of their brains develop. By adolescence, the brain's reward area, the striatum and other parts of the limbic system, is fully developed, but the frontal cortex, an area involved in decision making—evaluating whether the reward is worth the risk—is not fully matured until early adulthood. This difference means the evaluation of risks versus rewards performed by the is not fully engaged in adolescence.

"The fact that the is not fully developed means this is a developmental window and, as such, the use of drugs and alcohol during this period may unalterably inhibit the development of this key part of the brain," says VanMeter.

"Genes are thought to contribute to susceptibility of disorders, along with other factors such as family history, poverty, and use among friends," says lead author Veronica C. Mucciarone, a research assistant in VanMeter's lab. "The benefit of this study is that our results suggest that OPRM1 genotype influences the way the brain processes reward before exposure to drugs and alcohol, which is important because this allows us to examine how the gene affects their brains prior to being altered by substance use."

Researchers explored the effects of the G variation in early adolescence, before the participants began using substances. They scanned 115 adolescents, ages 11-13, using fMRI while they played a research-based computerized . In the game, participants made either risky choices (low odds of winning) or safe choices (high odds of winning), after which they were shown whether they won or lost money.

The study also analyzed self-reported family history of alcohol use/abuse, and while that parental survey found no significant difference between carriers of the OPRM1 G allele, and other alleles, a significant number of participants who carried the G allele reported that they believed their parents drank more alcohol than did the other group of participants.

"Taken together, results showing a heightened awareness of parental alcohol consumption and decreased brain response to reward suggest G-allele carriers may be at increased risk for substance use disorders," says Mucciarone.

VanMeter added, "This indicates that these adolescents have an altered system that we should pay attention to, and design prevention strategies to help these children."

More information: Differential brain response between OPRM1 genotypes to reward feedback during early adolescence - Abstract #7517

Citation: Opioid gene variant in adolescents reduces reward, may increase later substance abuse risk (2018, November 5) retrieved 23 May 2024 from https://medicalxpress.com/news/2018-11-opioid-gene-variant-adolescents-reward.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Impact of a genetic risk factor for substance use differs by sex in adolescents


Feedback to editors